Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
The University of Texas MD Anderson Cancer Center
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
221
total citations
- FWCI
- 53.84
- Percentile
- 100%
- References
- 32
Citations per year
Authors
28- JYJoe Y. ChangCorresponding
The University of Texas MD Anderson Cancer Center
- SHSteven H. Lin
The University of Texas MD Anderson Cancer Center
- WDWenli Dong
The University of Texas MD Anderson Cancer Center
- ZLZhongxing Liao
The University of Texas MD Anderson Cancer Center
- SGSaumil Gandhi
The University of Texas MD Anderson Cancer Center
Topics & keywords
Topics
Keywords
- Medicine
- Ablative case
- Lung
- Radiation therapy
- Lung cancer
- Immunotherapy
- Stage (stratigraphy)
- Open label
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.